drugset / Trial / NCT06198556
Effect of Rifampicin on the Pharmacokinetics of HRS-1167 in Healthy Subjects
NaSingle-groupOpen-labelTreatment
Summary
The primary objective of the study is to evaluate the effect of rifampicin on pharmacokinetics of healthy adult subjects after oral administration of HRS-1167 tablets. The secondary objective of the study is to evaluate the safety of HRS-1167 alone and when co-administered with rifampicin.
Timeline
- Start
- 2024-01-14
- Primary completion
- 2024-02-05
- Completion
- 2024-02-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-1167 | Unknown | — | Oral |
| Subject | Rifampin | Small molecule | — | — |